|Articles|June 1, 2019
- BioPharm International-06-01-2019
- Volume 43
- Issue 6
BioPharm International, June 2019 Issue (PDF)
Click the title above to open the BioPharm International June 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
FDA Advances New Approach to Drug Quality Assessmentover 6 years ago
Bio/Pharma Facilities Still Have a Lot to Learnover 6 years ago
Moving PAT from Concept to Realityover 6 years ago
Streamlining Upstream Processing: A Good Place to Startover 6 years ago
On the Right Trackover 6 years ago
Quality Agreements and Out-of-Specification Investigationsover 6 years ago
Addressing the Complex Nature of Downstream Processing with QbDover 6 years ago
From Data to InformationNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
5
